For citations:
Khasanov N.R. Empagliflozin: a path from glycemic control to reduced cardiovascular mortality and heart failure-related hospitalizations. Russian Journal of Cardiology. 2021;26(4S):4807. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4807
Views PDF (Rus): 624
Email this article 